A series of country profiles complement the study, featuring detailed data and additional analysis on the national dynamics. Country profiles are available for seven of the CEE countries: Bulgaria, Croatia, Czech Republic, Hungary, Poland, Slovakia and Slovenia. Romania has been included in this study as a comparator country. Additionally, you can find here a presentation outlining the background and objectives of the main study, as well as the key findings and recommendations for action.
At a turning point: Healthcare systems in Central and Eastern Europe
As governments rise to the challenge of managing the interlinked dynamics of population health and economic uncertainty, At a turning point: Healthcare systems in Central and Eastern Europe highlights the key differences and commonalities in healthcare financing and policy approaches across 13 European countries. The report, written by the Economist Impact, identifies major trends and aims to benchmark access and provision of healthcare services, medicines, healthcare outcomes as well as quality of care. It also puts forward a number of recommendations for action, in areas such as financing models, delivery of care, access to innovative treatments, diagnostics and digital infrastructure.
Related items
:focal())
News
20 May 2026
Healthcare, competitiveness, innovation and simplification
Europe’s life sciences sector sits at the heart of the EU’s competitiveness agenda. It supports advanced manufacturing and helps bring new treatments and technologies to patients. Yet companies deciding where to invest need a regulatory environment that is predictable and open to global cooperation.
The European Commission’s work on the Biotech Act and the targeted revision of the Medical Devices and In Vitro Diagnostics Regulations (MDR/IVDR) offers an opportunity to improve that environment. Both files can help make Europe a stronger location for life sciences investment.
The EU should use this moment to build a framework that keeps pace with scientific progress. That means faster and clearer procedures. It also means better use of data and intellectual property rules that recognise the realities of global supply chains.
:focal())
Position Paper
19 May 2026
Strengthening EU competitiveness through an adaptive MDR/IVDR framework
Position Paper
19 May 2026
A global approach to strengthening Europe’s biotechnology ecosystem
Policy priorities
Insights and advocacy driving Europe’s policy agenda. Our priorities support growth, innovation and a stronger transatlantic economy.
Membership
Connecting business and policymakers to strengthen the voice of American companies in Europe.